Walvax BioTech (300142) — Cash Flow-to-Debt Ratio
Walvax BioTech (300142) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-33.52 Million could theoretically repay 0% of its total liabilities (CN¥2.31 Billion) in one year. See 300142 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Walvax BioTech Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Walvax BioTech across 19 annual periods. Also explore 300142 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Walvax BioTech (2007–2025)
Year-by-year debt coverage analysis for Walvax BioTech. For market capitalisation and broader financial context, see Walvax BioTech (300142) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥494.37 Million | CN¥2.26 Billion | ▼ -32.0% |
| 2024 | 0.32x | CN¥1.04 Billion | CN¥3.22 Billion | ▲ +19.2% |
| 2023 | 0.27x | CN¥1.13 Billion | CN¥4.19 Billion | ▼ -2.2% |
| 2022 | 0.28x | CN¥1.20 Billion | CN¥4.35 Billion | ▲ +44.1% |
| 2021 | 0.19x | CN¥705.28 Million | CN¥3.68 Billion | ▲ +202.5% |
| 2020 | 0.06x | CN¥114.19 Million | CN¥1.80 Billion | ▲ +38.3% |
| 2019 | 0.05x | CN¥62.02 Million | CN¥1.35 Billion | ▲ +239.5% |
| 2018 | -0.03x | CN¥-65.23 Million | CN¥1.98 Billion | ▼ -653.0% |
| 2017 | 0.00x | CN¥-10.13 Million | CN¥2.32 Billion | ▲ +86.4% |
| 2016 | -0.03x | CN¥-89.94 Million | CN¥2.80 Billion | ▼ -49.6% |
| 2015 | -0.02x | CN¥-69.41 Million | CN¥3.23 Billion | ▲ +10.3% |
| 2014 | -0.02x | CN¥-65.93 Million | CN¥2.76 Billion | ▲ +37.2% |
| 2013 | -0.04x | CN¥-121.73 Million | CN¥3.20 Billion | ▼ -162.2% |
| 2012 | 0.06x | CN¥78.38 Million | CN¥1.28 Billion | ▼ -80.5% |
| 2011 | 0.31x | CN¥91.98 Million | CN¥293.62 Million | ▲ +57.3% |
| 2010 | 0.20x | CN¥86.71 Million | CN¥435.52 Million | ▼ -48.8% |
| 2009 | 0.39x | CN¥82.18 Million | CN¥211.43 Million | ▲ +1489.3% |
| 2008 | -0.03x | CN¥-5.69 Million | CN¥203.54 Million | ▼ -117.6% |
| 2007 | 0.16x | CN¥31.85 Million | CN¥199.86 Million | — |